August 29, 2024

ROSEN, A LONGSTANDING LAW FIRM, Encourages lululemon athletica inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LULU

NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of lululemon athletica inc. (NASDAQ: LULU) between December 7, 2023 and July 24, 2024, both dates inclusive (the “Class Period”), of the important October 7, 2024 lead plaintiff deadline. SO WHAT: If you purchased lululemon securities […]

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRNA

NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Moderna, Inc. (NASDAQ: MRNA) between January 18, 2023 and June 25, 2024, both dates inclusive (the “Class Period”), of the important October 8, 2024 lead plaintiff deadline. SO WHAT: If you purchased Moderna securities during […]

ROSEN, LEADING INVESTOR COUNSEL, Encourages Methode Electronics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MEI

NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Methode Electronics, Inc. (NYSE: MEI) between June 23, 2022 and March 6, 2024, both dates inclusive (the “Class Period”). A class action […]

CVS FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages CVS Health Corporation Investors to Secure Counsel Before Important September 10 Deadline in Securities Class Action – CVS

NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of CVS Health Corporation (NYSE: CVS) between May 3, 2023 and April 30, 2024, both dates inclusive (the “Class Period”), of the important September 10, 2024 lead plaintiff deadline. SO WHAT: If you purchased CVS Securities […]